Mariana O. Nunes

Porto, 4050313, Portugal

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Anti-PD-1 Treatment Restores Effector Function in Exhausted-like T Cells from Malignant Ascites of Ovarian Cancer Patients.

Anti-PD-1 Treatment Restores Effector Function in Exhausted-like T Cells from Malignant Ascites of Ovarian Cancer Patients.

Journal: Cancers

Published: June 22, 2026

Re-Thinking Pharmacokinetics in Ovarian Cancer: What Do Organoids Add?

Re-Thinking Pharmacokinetics in Ovarian Cancer: What Do Organoids Add?

Journal: International journal of molecular sciences

Published: March 10, 2026

Tracking Chemotherapy Effects via ALDH1A1, SOX2, CD44v6, and P-gp Expression in Malignant Ascites from High-Grade Serous Carcinoma.

Tracking Chemotherapy Effects via ALDH1A1, SOX2, CD44v6, and P-gp Expression in Malignant Ascites from High-Grade Serous Carcinoma.

Journal: Pathobiology : journal of immunopathology, molecular and cellular biology

Published: November 18, 2025

Galanthamine Fails to Reverse P-gp-Mediated Paclitaxel Resistance in Ovarian Cancer Cell Lines.

Galanthamine Fails to Reverse P-gp-Mediated Paclitaxel Resistance in Ovarian Cancer Cell Lines.

Journal: Biomedicines

Published: October 27, 2025

Paclitaxel resistance-associated metabolic events in ovarian cancer cells.

Paclitaxel resistance-associated metabolic events in ovarian cancer cells.

Journal: Metabolomics : Official journal of the Metabolomic Society

Published: July 07, 2025

Metformin Impairs Linsitinib Anti-Tumor Effect on Ovarian Cancer Cell Lines.

Metformin Impairs Linsitinib Anti-Tumor Effect on Ovarian Cancer Cell Lines.

Journal: International journal of molecular sciences

Published: October 16, 2024

Deciphering the Molecular Mechanisms behind Drug Resistance in Ovarian Cancer to Unlock Efficient Treatment Options.

Deciphering the Molecular Mechanisms behind Drug Resistance in Ovarian Cancer to Unlock Efficient Treatment Options.

Journal: Cells

Published: April 19, 2024

Ovarian cancer ascites proteomic profile reflects metabolic changes during disease progression.

Ovarian cancer ascites proteomic profile reflects metabolic changes during disease progression.

Journal: Biochemistry and biophysics reports

Published: April 17, 2024

The Antineoplastic Effect of Carboplatin Is Potentiated by Combination with Pitavastatin or Metformin in a Chemoresistant High-Grade Serous Carcinoma Cell Line.

The Antineoplastic Effect of Carboplatin Is Potentiated by Combination with Pitavastatin or Metformin in a Chemoresistant High-Grade Serous Carcinoma Cell Line.

Journal: International journal of molecular sciences

Published: December 09, 2022

Combination of Antimalarial and CNS Drugs with Antineoplastic Agents in MCF-7 Breast and HT-29 Colon Cancer Cells: Biosafety Evaluation and Mechanism of Action.

Combination of Antimalarial and CNS Drugs with Antineoplastic Agents in MCF-7 Breast and HT-29 Colon Cancer Cells: Biosafety Evaluation and Mechanism of Action.

Journal: Biomolecules

Published: September 03, 2022

InfectionCMA: A Cell MicroArray Approach for Efficient Biomarker Screening in In Vitro Infection Assays.

InfectionCMA: A Cell MicroArray Approach for Efficient Biomarker Screening in In Vitro Infection Assays.

Journal: Pathogens (Basel, Switzerland)

Published: February 07, 2022

Corrigendum: Generation of Two Paclitaxel-Resistant High-Grade Serous Carcinoma Cell Lines With Increased Expression of P-Glycoprotein.

Corrigendum: Generation of Two Paclitaxel-Resistant High-Grade Serous Carcinoma Cell Lines With Increased Expression of P-Glycoprotein.

Journal: Frontiers in oncology

Published: January 12, 2022

Showing 1-12 of 17

Last Updated: 09/26/2026